Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 07, 2019

SELL
$8.12 - $15.72 $84,918 - $164,399
-10,458 Closed
0 $0
Q1 2019

May 08, 2019

BUY
$15.58 - $20.01 $4,720 - $6,063
303 Added 2.98%
10,458 $164,000
Q3 2018

Nov 02, 2018

SELL
$21.06 - $25.65 $2,295 - $2,795
-109 Reduced 1.06%
10,155 $218,000
Q2 2018

Aug 08, 2018

SELL
$16.77 - $24.71 $905 - $1,334
-54 Reduced 0.52%
10,264 $250,000
Q1 2018

May 03, 2018

SELL
$16.68 - $22.07 $135,942 - $179,870
-8,150 Reduced 44.13%
10,318 $176,000
Q4 2017

Feb 12, 2018

SELL
$11.23 - $19.1 $50,826 - $86,446
-4,526 Reduced 19.68%
18,468 $350,000
Q3 2017

Nov 07, 2017

BUY
$15.41 - $32.17 $7,088 - $14,798
460 Added 2.04%
22,994 $764,000
Q3 2017

Nov 07, 2017

BUY
$15.41 - $32.17 $347,248 - $724,918
22,534
22,534 $397,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $20.6B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Commerce Bank Portfolio

Follow Commerce Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerce Bank, based on Form 13F filings with the SEC.

News

Stay updated on Commerce Bank with notifications on news.